SUPPLEMENTARY INFORMATION
Figures in R million |
Six months ended 31 August 2011 (Unaudited) |
Six months ended 31 August 2010 (Unaudited) |
Year ended 28 February 2011 (Audited) |
| Depreciation and amortisation | 160 |
146 |
285 |
| Capital expenditure | 87 |
169 |
264 |
| Capital commitments | 32 |
52 |
67 |
| Lease commitments | 167 |
160 |
238 |
| Payable within the next 12 months: | 77 |
91 |
95 |
| – Property | 46 |
53 |
50 |
| – Plant, equipment and vehicles | 31 |
38 |
45 |
| Payable thereafter: | 90 |
69 |
143 |
| – Property | 64 |
32 |
59 |
| – Plant, equipment and vehicles | 26 |
37 |
84 |
| Net foreign exchange losses |
|||
| (including FEC fair value adjustment) | (22) |
(10) |
(3) |
| Ordinary shares in issue (million) | |||
| – weighted average | 97,479 |
97,374 |
97,389 |
| – diluted average | 99,561 |
98,668 |
98,677 |
| – at end of the period | 97,488 |
97,374 |
97,458 |
| Ratios | |||
| EBITDA to revenue (%) | 9,4 |
10,6 |
11,1 |
| Operating profit to revenue (%) | 6,1 |
7,5 |
8,2 |
| Return on shareholders’ equity (%) | 15,4* |
21,7* |
22,2 |
| Return on capital employed (%) | 29,1* |
31,3* |
32,9 |
| Return on operating assets (%) | 21,9* |
29,0* |
29,8 |
| Current ratio | 1.1:1 |
1.0:1 |
1.1:1 |
| Acid test ratio | 0.9:1 |
0.8:1 |
0.9:1 |
| Net asset value per share (cents) | 2 031 |
1 904 |
2 193 |
* Annualised
